Extrapleural infusion of levobupivacaine versus levobupivacaine‐sufentanil‐adrenaline after video‐assisted thoracoscopic surgery (VATS): A randomised controlled trial

Abstract

AbstractBackgroundPeripheral blocks are increasingly used for analgesia after video‐assisted thoracic surgery (VATS). We hypothesised that addition of sufentanil and adrenaline to levobupivacaine would improve the analgesic effect of a continuous extrapleural block.MethodsWe randomised 60 patients undergoing VATS to a 5‐mL h−1 extrapleural infusion of levobupivacaine at 2.7 mg mL−1 (LB group) or levobupivacaine at 1.25 mg mL−1, sufentanil at 0.5 μg mL−1, and adrenaline at 2 μg mL−1 (LBSA group). The primary outcome was the cumulative morphine dose administered as patient‐controlled analgesia (PCA‐morphine) at 48 and 72 h. The secondary outcomes were pain according to numerical rating scale (NRS) at rest and after two deep breaths twice daily, peak expiratory flow (PEF) daily, quality of recovery (QoR)‐15 score at 1 day and 3 weeks postoperatively, serum levobupivacaine concentrations at 1 h after the start and at the end of the intervention, and adverse events.ResultsAt 48 h, the median cumulative PCA‐morphine dose for the LB group was 6 mg (IQR, 2–10 mg) and for the LBSA group 7 mg (IQR, 3–13.5 mg; p = .378). At 72 h, morphine doses were 10 mg (IQR, 3–22 mg) and 12.5 mg (IQR, 4–21 mg; p = .738), respectively. Median NRS score at rest and after two deep breaths was 3 or lower at all time points for both treatment groups. PEF did not differ between groups. Three weeks postoperatively, only the LB group returned to baseline QoR‐15 score. The LB group had higher, but well below toxic, levobupivacaine concentrations at 48 and 72 h. The incidence of nausea, dizziness, pruritus and headache was equally low overall.ConclusionFor a continuous extrapleural block, and compared to plain levobupivacaine at 13.5 mg h−1, levobupivacaine at 6.25 mg h−1 with addition of sufentanil and adrenaline did not decrease postoperative morphine consumption. The levobupivacaine serum concentrations after 48 and 72 h of infusion were well below toxic levels, therefore our findings support the use of the maximally recommended dose of levobupivacaine for a 2‐ to 3‐day continuous extrapleural block.